Get notified when ADTX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Standing Risk Factors

  • Going Concern (unchanged) — Auditor's going-concern opinion persists; accumulated deficit grew to $209.8M from $168.1M.
  • Material Weakness (unchanged) — Four material weaknesses in internal controls continue from prior year with no remediation disclosed.
NASDAQ: ADTX Aditxt, Inc. 10-K

Aditxt loses Evofem merger, takes $23.8M writedown; Nasdaq equity deficiency threatens delisting

Filed March 31, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 31, 2025 · ~2 min read

Key Changes

  • high

    Evofem merger terminated Oct 2025 after shareholder vote failed; Aditxt took $23.8M fair-value loss on retained Evofem preferred stock, driving net loss to $42.8M (up 22% YoY). Company keeps minority Evofem securities but loses women's-health expansion strategy.

    MD&A: Evofem Transaction verify on EDGAR →
  • high

    Nasdaq issued Dec 2025 deficiency notice for stockholders' equity below $2.5M threshold; company granted extension to May 15, 2026, to cure. Proposed Nasdaq rule would allow immediate delisting if market cap stays below $5M for 30 days—company's current cap is $713k.

    Risk Factors: Nasdaq Compliance verify on EDGAR →
  • high

    Revenue collapsed 98% to $3k in FY2025 (from $134k in FY2024) as COVID testing demand for AditxtScore evaporated. Working capital deficit improved to negative $8.4M from negative $21.4M, suggesting capital raise offset operating burn.

    MD&A: Revenue & Liquidity verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (PXED 10-Q) is open in full — no account needed.

Partner

Trade ADTX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov View full financials on EDGAR ↗

Source-verified from EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify